Metformin’s effect in AD is controversial, with some studies reporting patient benefits [43] but others finding that it worsened cognitive performance [44], possibly related to metformin’s ability to increase APP levels and processing to increase Aβ production [45]. The gene discussed is APP; the disease is Alzheimer disease.